Momentum Therapeutics

Momentum Therapeutics develops therapeutic drugs targeting age-associated conditions of the central and peripheral nervous systems, particularly neurodegenerative diseases. The company uses proteomics data and computational approaches to identify protein changes in aging brains and discover existing or novel drugs that can restore normal protein configuration to treat age-related neurological conditions.